CD34 and hepatocellular carcinoma: To test this hypothesis, we firstly examined the expression levels of Nogo‐B and CD34, a marker of vascular, in two TMA containing 211 cases of HCC specimens by immunohistochemical staining using anti‐Nogo‐B and anti‐CD34 antibodies, respectively (Fig. S1).